Biosimilar medicine fact sheet – trastuzumab

This fact sheet provides information about biosimilar brands of trastuzumab listed on the Pharmaceutical Benefits Scheme (PBS).

Downloads

Biosimilar medicine fact sheet – trastuzumab

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Publication type:
Fact sheet
Audience:
General public
Language:
English
Description:
  • Ogivri® was listed on the PBS on 1 August 2019.
  • Herzuma® was listed on the PBS on 1 November 2019.
  • Kanjinti® was listed on the PBS on 1 December 2019.
  • Ontruzant® was listed on the PBS on 1 January 2020.
  • Trazimera® was listed on the PBS on 1 May 2020.

These brands are listed under the Efficient Funding of Chemotherapy arrangements of the Section 100 Highly Specialised Drugs Program.

Tags: 

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.